Iododoxorubicin
Iododoxorubicin is a derivative of Doxorubicin and anticancer agent. Iododoxorubicin has stronger activity against Lewis lung carcinoma than Doxorubicin[1][2].
Product Specifications
CAS Number
83997-75-5
UNSPSC
12352005
Target
Drug Derivative
Related Pathways
Others
Field of Research
Cancer
Smiles
[H][C@]1(O[C@H]2C[C@@](CC3=C(C(C(C4=C5C(OC)=CC=C4)=O)=C(C(O)=C23)C5=O)O)(C(CO)=O)O)C[C@@H]([C@@H]([C@@H](O1)C)I)N
Molecular Formula
C27H28INO10
Molecular Weight
653.42
References & Citations
[1]Berger I, et al. Molecular structure of the halogenated anti-cancer drug iododoxorubicin complexed with d (TGTACA) and d (CGATCG) . Nucleic Acids Res. 1995 Nov 11;23 (21) :4488-94. |[2]Twelves CJ, et al. Dobbs NA, Lawrence MA, Ramirez AJ, Summerhayes M, Richards MA, Towlson KE, Rubens RD. Iododoxorubicin in advanced breast cancer: a phase II evaluation of clinical activity, pharmacology and quality of life. Br J Cancer. 1994 Apr;69 (4) :726-31.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941908-100 1x 100 µL
PAX5 / BSAP (Early B-Cell Marker) (PCRP-PAX5-1B7), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
AP51010PU-N 400 µL
Collagen XVII (COL17A1) (Center) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
